| DAIICHI SANKYO CO. LTD |
| Japan |
| Gesundheit |
| JP3475350009 / A0F57T |
| D4S (Frankfurt) |
| FRA:D4S, ETR:D4S, D4S:GR |
| Nikkei225 |
| https://www.daiichisankyo.. |
|
Daiichi Sankyo Co., Ltd. is a Japan-based pharmaceutical company specializing in the research, development, and commercialization of innovative medicines. Formed in 2005 through the merger of Daiichi Pharmaceutical and Sankyo, the company focuses pri..
>Volltext.. |
| 29212.48 Mio. EUR |
| 27904.31 Mio. EUR |
| 11344.18 Mio. EUR |
| 2136.83 Mio. EUR |
| 1683.81 Mio. EUR |
| 0.91 EUR |
| 1661.45 Mio. EUR |
| 2993.12 Mio. EUR |
| 684.7 Mio. EUR |
| 0.7 |
| 1.04% |
| 9.6% |
| 0.22 EUR |
| 2.35% |
| 2.73% |
| 29.09.25 - 0.2222064€ 28.03.25 - 0.170928€ >weitere anzeigen... |
| - |
| DAIICHI SANKYO |
| 03.04.26 |
|